A national fund of €5.3 Million has been created to counter act Covid-19, this fund will enable Research and Development projects to not only address innovative and/or improved approaches related to the current pandemic, but also potential future waves and other antiviral relevant research.
If you feel that you / your company can contribute towards the prevention, control or restraint of infectious diseases get in touch with us to help you gain access to the available funds.
Contact: Alison Mizzi – eu-funding@emcs.com.mt
